A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species

Microevolution of Serial Clinical Isolates of Cryptococcus neoformans var. grubii and C. gattii

(2017) Yuan Chen et al.   mBio

Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update

(2017) The Southern African HIV Clinicians Society   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil

(2016) P. F. Herkert et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Susceptibility profile and epidemiological cut-off values ofCryptococcus neoformansspecies complex from Argentina

(2016) Susana Córdoba et al.   MYCOSES

Molecular identification, antifungal resistance and virulence ofCryptococcus neoformansandCryptococcus deneoformansisolated in Seville, Spain

(2016) Sara Gago et al.   MYCOSES

Molecular epidemiology andin vitroantifungal susceptibility testing of 108 clinicalCryptococcus neoformans sensu latoandCryptococcus gattii sensu latoisolates from Denmark

(2016) Ferry Hagen et al.   MYCOSES

Molecular epidemiology reveals genetic diversity among 363 isolates of theCryptococcus neoformansandCryptococcus gattiispecies complex in 61 Ivorian HIV-positive patients

(2016) Fulgence K. Kassi et al.   MYCOSES

ANTIFUNGAL SUSCEPTIBILITY TESTING AND GENOTYPING CHARACTERIZATION OF Cryptococcus neoformans AND gattii ISOLATES FROM HIV-INFECTED PATIENTS OF RIBEIRÃO PRETO, SÃO PAULO, BRAZIL

(2016) Thais Pandini FIGUEIREDO et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012

(2016) Erika Britz et al.   PLoS One

Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

(2015) Kyle D. Smith et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study

(2015) Yi-Chun Chen et al.   BMC INFECTIOUS DISEASES

Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole

(2015) T. Kammalac Ngouana et al.   JOURNAL DE MYCOLOGIE MEDICALE

SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY

(2015) Ana ALASTRUEY-IZQUIERDO et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole

(2015) Carlos Andrés Agudelo et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Multilocus Sequence Typing of Serially Collected Isolates of Cryptococcus from HIV-Infected Patients in South Africa

(2014) M. Van Wyk et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Combination Antifungal Therapy for Cryptococcal Meningitis

(2013) Jeremy N. Day et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis

(2012) Chen-Hsiang Lee et al.   BMC INFECTIOUS DISEASES

In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia

(2012) A. Trpković et al.   JOURNAL DE MYCOLOGIE MEDICALE

Fluconazole resistance in cryptococcal disease: emerging or intrinsic?

(2012) Jenny Wan Sai Cheong et al.   MEDICAL MYCOLOGY

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008

(2011) Nelesh P. Govender et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

(2011) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro antifungal susceptibilities and molecular typing of sequentially isolated clinical Cryptococcus neoformans strains from Croatia

(2011) E. Mlinaric-Missoni et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya

(2011) Rennatus Mdodo et al.   MYCOSES

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Antifungal susceptibility, serotyping, and genotyping of clinicalCryptococcus neoformansisolates collected during 18 years in a single institution in Madrid, Spain

(2010) Jesús Guinea et al.   MEDICAL MYCOLOGY

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence

(2009) E. Sionov et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: Results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy

(2009) Alicia Irene Arechavala et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

(2007) Z. A. Kanafani et al.   CLINICAL INFECTIOUS DISEASES